Paricalcitol, a synthetic vitamin D analog: A candidate for combination therapy with biological agents in rheumatoid arthritis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Tae-Hwan | - |
dc.contributor.author | Ji, Jong Dae | - |
dc.date.accessioned | 2022-12-20T10:49:56Z | - |
dc.date.available | 2022-12-20T10:49:56Z | - |
dc.date.created | 2022-08-26 | - |
dc.date.issued | 2010-12 | - |
dc.identifier.issn | 0306-9877 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/173363 | - |
dc.description.abstract | Biologic agents, especially TNF alpha inhibitors, appear to be very effective in treatment of rheumatoid arthritis (RA). Although the use of biologic agents has greatly improved the therapeutic efficacy in management of RA, biologic therapies for RA treatment have several limitations. These agents fail to achieve complete remission in substantial portion of RA patients. Also certain adverse events have been observed, including serious bacterial infections and reactivation of latent tuberculosis. Previous reports demonstrated that TNF alpha inhibitors are more efficacious in combination with other drugs such as methotrexate. In this report, we suggest that paricalcitol, a synthetic vitamin D analog is another candidate molecule for combination therapy with TNF alpha inhibitors in RA. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | CHURCHILL LIVINGSTONE | - |
dc.title | Paricalcitol, a synthetic vitamin D analog: A candidate for combination therapy with biological agents in rheumatoid arthritis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Tae-Hwan | - |
dc.identifier.doi | 10.1016/j.mehy.2010.08.003 | - |
dc.identifier.scopusid | 2-s2.0-77958457182 | - |
dc.identifier.wosid | 000286918300046 | - |
dc.identifier.bibliographicCitation | MEDICAL HYPOTHESES, v.75, no.6, pp.634 - 635 | - |
dc.relation.isPartOf | MEDICAL HYPOTHESES | - |
dc.citation.title | MEDICAL HYPOTHESES | - |
dc.citation.volume | 75 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 634 | - |
dc.citation.endPage | 635 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | AUTOIMMUNE-DISEASES | - |
dc.subject.keywordPlus | DENDRITIC CELLS | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | MATURATION | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | MICE | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S030698771000304X?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.